USA compounding pharmaceutical Market to reach USD 6.80 Billion by 2027

USA compounding pharmaceutical Market Size study, by Product Type (Oral medications, Topical medication, suppositories and others), by Therapeutic area (Pain medications, Hormone replacement therapies, Dermatological Distribution Channels and others), by Distribution Channel (Compounding pharmacies and Traditional stores) and Regional Forecasts 2020-2027
Product Code:  HALHS_23606733
Chapter 1.	Executive Summary 
1.1.	Market Snapshot
1.2.	USA & Segmental Market Estimates & Forecasts, 2018-2027 (USD Billion)
1.2.1.	Compounding Pharmaceuticals Market, by Product Type, 2018-2027 (USD Billion)
1.2.2.	Compounding Pharmaceuticals Market, by Therapeutic area, 2018-2027 (USD Billion)
1.2.3.	Compounding Pharmaceuticals Market, by Distribution Channel, 2018-2027 (USD Billion)
1.3.	Key Trends
1.4.	Estimation Methodology
1.5.	Research Assumption
Chapter 2.	USA Compounding Pharmaceuticals Market Definition and Scope 
2.1.	Objective of the Study
2.2.	Market Definition & Scope
2.2.1.	Scope of the Study
2.2.2.	Industry Evolution
2.3.	Years Considered for the Study
2.4.	Currency Conversion Rates
Chapter 3.	USA Compounding Pharmaceuticals Market Dynamics	
3.1.	Compounding Pharmaceuticals Market Impact Analysis (2018-2027)
3.1.1.	Market Drivers
3.1.2.	Market Challenges
3.1.3.	Market Opportunities
Chapter 4.	USA Compounding Pharmaceuticals Market: Industry Analysis
4.1.	Porter’s 5 Force Model
4.1.1.	Bargaining Power of Suppliers
4.1.2.	Bargaining Power of Buyers
4.1.3.	Threat of New Entrants
4.1.4.	Threat of Substitutes
4.1.5.	Competitive Rivalry
4.1.6.	Futuristic Approach to Porter’s 5 Force Model (2017-2027)
4.2.	PEST Analysis
4.2.1.	Political 
4.2.2.	Economical
4.2.3.	Social 
4.2.4.	Technological 
4.3.	Investment Adoption Model
4.4.	Analyst Recommendation & Conclusion
Chapter 5.	USA Compounding Pharmaceuticals Market, by Product Type 
5.1.	Market Snapshot 
5.2.	USA Compounding Pharmaceuticals Market by Product Type, Performance - Potential Analysis
5.3.	USA Compounding Pharmaceuticals Market Estimates & Forecasts by Product Type 2017-2027 (USD Billion)
5.4.	Compounding Pharmaceuticals Market, Sub Segment Analysis
5.4.1.	 Oral medications
5.4.2.	 Topical medications 
5.4.3.	 Suppositories
5.4.4.	 Others
Chapter 6.	USA Compounding Pharmaceuticals Market, by Therapeutic area
6.1.	Market Snapshot 
6.2.	USA Compounding Pharmaceuticals Market by Therapeutic area, Performance - Potential Analysis
6.3.	USA Compounding Pharmaceuticals Market Estimates & Forecasts by Therapeutic area 2017-2027 (USD Billion)
6.4.	Compounding Pharmaceuticals Market, Sub Segment Analysis
6.4.1.	 Pain medications
6.4.2.	 Hormone replacement therapies
6.4.3.	 Dermatological applications 
6.4.4.	 Others
Chapter 7.	USA Compounding Pharmaceuticals Market, by Distribution channel          
7.1.	Market Snapshot 
7.2.	USA Compounding Pharmaceuticals Market by Distribution channel, Performance - Potential Analysis
7.3.	USA Compounding Pharmaceuticals Market Estimates & Forecasts by Distribution channel 2017-2027 (USD Billion)
7.4.	Compounding Pharmaceuticals Market, Sub Segment Analysis
7.4.1.	 Compounding pharmacies
7.4.2.	 Traditional stores
Chapter 8.	Competitive Intelligence
8.1.	Top Market Strategies
8.2.	Company Profiles
8.2.1.	 Fagron
8.2.1.1.	Key Information
8.2.1.2.	Overview
8.2.1.3.	Financial (Subject to Data Availability)
8.2.1.4.	Product Type Summary
8.2.1.5.	Recent Developments
8.2.2.	 Institutional pharmacy solutions
8.2.3.	B.Braun Melsungen AG Company
8.2.4.	Athenex pharma solution
8.2.5.	 Nephron pharmaceuticals corporation
8.2.6.	 Triangle compounding pharmacy
8.2.7.	 Fresenius Kabi AG
8.2.8.	 Rx3 compounding pharmacy
8.2.9.	 Clinigen group Plc
8.2.10.	 Pencol compounding pharmacy
Chapter 9.	Research Process
9.1.	Research Process
9.1.1.	Data Mining
9.1.2.	Analysis
9.1.3.	Market Estimation
9.1.4.	Validation
9.1.5.	Publishing
9.2.	Research Attributes
9.3.	Research Assumption

USA compounding pharmaceutical Market is valued approximately at USD 4.51 Billion in 2019 and is anticipated to grow with a healthy growth rate of more than 5.60% over the forecast period 2020-2027. Compounding is the preparation of a personalized drug mixture to meet a patient’s specific need that cannot be fulfilled by drugs that are commercially available. The compounding pharmaceuticals is gaining a significant demand from various therapeutic areas such pain medication, dermatological applications, hormone replacement therapies and others. Therefore, rising number of skin conditions is stimulating the growth of market over the forecast years. According to the American Academy of Dermatology Association, the primary skin conditions rampant among individuals in the United States include acne, psoriasis and atopic dermatitis. The compounding pharmaceuticals are precisely recommended by the doctors & dermatologists for the common skin conditions such as acne and psoriasis. Acne is the most common skin condition which affects around 50 million American population every year. Around 85% of the individuals belonging to the age group of 12 to 24 years suffers at least one minor acne. In the present scenario, acne is on the escalating mode in the United States subsequently affecting up to 15% of female population in the country. In addition, Atopic dermatitis is considered as one of the leading skin conditions prevalent among the American population. According to American Academy of Dermatology Association, 1 in 10 individuals in United States would develop atopic dermatitis during their lifetime. The prevalence of atopic dermatitis impacts around 25% of the adolescent and 2-3% of adults in United States every year. Additionally, surging rate of geriatric population is driving the growth of market over the forecast years. However, Denied approval from Food & Drug administration for compounding pharmaceuticals is restraining the growth of market.

Major market player included in this report are:
Fagron
Institutional pharmacy solutions
B.Braun Melsungen AG Company
Athenex pharma solution
Nephron pharmaceuticals corporation
Triangle compounding pharmacy
Fresenius Kabi AG
Rx3 compounding pharmacy
Clinigen group Plc
Pencol compounding pharmacy

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and Product Type offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product Type:
Oral medications
Topical medications
Suppositories
Others

By Therapeutic area:
Pain medications
Hormone replacement therapies
Dermatological applications
Others

By Distribution Channel:
Compounding pharmacies
Traditional stores

Furthermore, years considered for the study are as follows:

Historical year – 2017, 2018
Base year – 2019
Forecast period – 2020 to 2027

Target Audience of the USA compounding pharmaceutical Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors


We offer 10% free customization including country-level data, niche applications and competitive landscape with every report. This also includes a 30 minute free analyst discussion post report purchase.

Full Name*

Business Email* (Please avoid generic email IDs such as gmail, yahoo)

Phone* (Please Affix Country Code)

Need specific market information? To get a customized report, please share your exact research requirements.



Loading…